Cargando…
DNA methyltransferase 1 inhibits microRNA-497 and elevates GPRC5A expression to promote chemotherapy resistance and metastasis in breast cancer
BACKGROUND: Abnormal DNA methylation of tumor suppressor gene promoter has been found in breast cancer. Therefore, the current study set out to explore how DNA methyltransferase 1 (DNMT1) affects breast cancer through mediating miR-497/GPRC5A axis. METHODS: After loss and gain-of-function approaches...
Autores principales: | Liu, Yaobang, Bai, Zhengyang, Chai, Dahai, Gao, Yali, Li, Ting, Ma, Yinling, Li, Jinping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8903738/ https://www.ncbi.nlm.nih.gov/pubmed/35255904 http://dx.doi.org/10.1186/s12935-022-02466-5 |
Ejemplares similares
-
MicroRNA-1297 downregulation inhibits breast cancer cell epithelial-mesenchymal transition and proliferation in a FA2H-dependent manner
por: Li, Hong, et al.
Publicado: (2020) -
Knockdown of LINC00702 inhibits the growth and induces apoptosis of breast cancer through the Wnt/β-catenin pathway
por: Chai, Dahai, et al.
Publicado: (2023) -
Exosomes Derived from Tumor Cells Initiate Breast Cancer Cell Metastasis and Chemoresistance through a MALAT1-Dependent Mechanism
por: Tao, Shuang, et al.
Publicado: (2022) -
IMUP and GPRC5A: two newly identified risk score indicators in pancreatic ductal adenocarcinoma
por: Wei, Rong, et al.
Publicado: (2021) -
Integrated analyses of microRNA-29 family and the related combination biomarkers demonstrate their widespread influence on risk, recurrence, metastasis and survival outcome in colorectal cancer
por: Peng, Qiliang, et al.
Publicado: (2019)